Menu
Log in


Blog Post

Australia and New Zealand Consensus Position Statement: Use of COVID-19 therapeutics in patients with Haematological malignancies

5 May 2022 10:11 AM | HSANZ Office (Administrator)

Australia and New Zealand Consensus Position Statement: Use of COVID-19 therapeutics in patients with Haematological malignancies

Attached is the final version of the above consensus position statement. Click here for document



OFFICE
145 Macquarie Street,
Sydney NSW 2000
hsanz@hsanz.org.au


 © 2025 Haematology Society of Australia & New Zealand. All Rights Reserved.

Powered by Wild Apricot Membership Software